News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of AKR-001 in Subjects with Nonalcoholic Steatohepatitis (NASH)

Study Status:

Closed for enrollment

Contact Information:

(956) 362-8047

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The primary objective of this study is to evaluate absolute change from baseline in hepatic fat fraction assessed by Magnetic Resonance Imaging – Proton Density Fat Fraction (MRI-PDFF) at Week 12


Principal Investigator
Dr. Rama Behara, DO
Guillermo Duran
Akero Therapeutics, Inc.
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram